Expression of maspin in non-small-cell lung cancer: Correlation with clinical features

Clinical Lung Cancer

Volumn 9, Issue 6, 2008, Pages 361-366

  Takanami, Lwao ^a   Abiko, Tomohiro ^a   Koizumi, Satoko ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Microvessel density; Prognostic factors; Squamous cell carcinoma

Indexed keywords

MASPIN;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION;

EID: 59449084268     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2008.n.052     Document Type: Article

References (25)

1. Ginsberg R, Vokes E, Raben A. Non-small cell lung cancer. In: deVita V Jr, Hallman S, Rosenberg S, editors. Cancer: Principles and Practice of Oncology. Philadelphia: Lippencott-Raven; 1997. p. 858-911.
2. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994; 263:526-9.
3. Pemberton PA, Tripton AR, Pavloff MC. Maspin is an intracellular serpine that partitions into secretary vesicles and in present at the cell surface. J Histochem Cytochem 1997; 45:1697-706.
4. Maass N, Hogo T, Rosel F, et al. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 2001; 34:303-7.
5. Maass N, Treffner M, Rosel F, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 2001; 195:321-6.
6. Maass N, Hogo T, Ueding M, et al. Expression of tumor suppressor gene maspin in human cancers. Clin Cancer Res 2001; 6:812-7.
7. Umekita Y, Ohi Y, Sagaya Y, et al. Expression of maspin predicts poor prognosis in breast-cancer patients. Int J Cancer 2002; 100:452-5.
8. Bieche I, Girault I, Sabourin JC, et al. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas. Br J Cancer 2003; 88:863-70.
9. Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002; 8:2924-32.
10. Maass N, Hojo T, Ueding M, et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 2001; 7:812-7.
11. Nakashima M, Ohike N, Nagasaki K, et al. Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma. J Cancer Res Clin Oncol 2004; 130:475-9.
12. Nakagawa M, Kitakura H, Adachi M, et al. Maspin expression and its clinical significance in non-small cell lung cancer. Ann Surg Oncol 2006; 13:1517-23.
13. Katakura H, Takenaka K, Nakagawa M, et al. Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Lung Cancer 2006; 51:323-8.
14. Hirai K, Koizumi K, Haraguchi S, et al. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Ann Thorac Surg 2005; 79:248-53.
15. Woenckhaus M, Budendorf L, Dalquen P, et al. Nuclear and cytoplasmic maspin expression in primary non-small cell lung cancer. J Clin Pathol 2007; 60:483-6.
16. Takanami I, Takeuchi K, Kodaira D. Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis.
17. Oncology 1999; 57:138-42.
18. Zou Z, Gao C, Nagaich AK, et al. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 2000; 275:6051-4.
19. Zhang M, Volpert O, Shi YH, et al. Maspin is an angiogenesis inhibitor. Nat Med 2000; 6:196-9.
20. Domann FE, Rice JC, Hendrix MJ, et al. Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 2000; 85:805-10.
21. Machtens S, Serth J, Bokemeyer C, et al. Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 2001; 95:337-42.
22. Zhang M, Maass N, Magit D, et al. Transactivation through Ets and AP1 transcriptional sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 1997; 8:179-86.
23. Xia W, Lau YK, Hu MC, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 2000; 19:2398-403.
24. Zhang M, Volpert O, Shi YH, et al. Maspin is an angiogenesis inhibitor. Nat Med 2000; 6:196-9.
25. Friedrich MG, Toma MI, Petri S, et al. Expression of maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Eur Urol 2004; 45:737-43.